Measuring persistence to hormonal therapy in patients with breast cancer: accounting for temporary treatment discontinuation-Reference-Cited by-同舟云学术

Measuring persistence to hormonal therapy in patients with breast cancer: accounting for temporary treatment discontinuation

Published:2014-04-30 Issue:8 Volume:23 Page:882-889
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Huiart Laetitia¹²³,Ferdynus Cyril¹,Dell'Aniello Sophie⁴,Bakiri Naciba⁵,Giorgi Roch²³⁶,Suissa Samy⁴⁷

Affiliation:

1. Unité de Soutien Méthodologique; CHU La Réunion; Saint-Denis France

2. INSERM, U912 (SESSTIM); Marseille France

3. Université Aix Marseille, IRD, UMR-S912; Marseille France

4. Center for Clinical Epidemiology and Community Studies; Sir Mortimer B Davies Jewish General Hospital; Montreal Quebec Canada

5. Service d'Oncologie Clinique; CHU La Réunion; Saint-Denis France

6. Service Biostatistique et Technologies de l'Information et de la Communication, Hôpital de la Timone; Assistance Publique-Hopitaux de Marseille; Marseille France

7. Department of Epidemiology, Biostatistics and Occupational Health; McGill University; Montreal Quebec Canada

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pds.3631/fullpdf

Reference43 articles.

1. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Early Breast Cancer Trialists' Collaborative Group;Lancet,2005

2. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group;Early Breast Cancer Trialists' Collaborative Group;Lancet,1998

3. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial;Davies;Lancet,2013

4. Tamoxifen therapy for patients with breast cancer;Huiart;Lancet,2013

5. Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review;Murphy;Breast Cancer Res Treat,2012

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beliefs, attitudes and acceptance towards an eHealth tool to support oral hormonal therapy in breast cancer: A qualitative study. (Preprint);2020-11-27

2. Fatores associados à adesão e à persistência na hormonioterapia em mulheres com câncer de mama;Revista Brasileira de Epidemiologia;2017-12

3. Immeasurable time bias due to hospitalization in medico-administrative databases: which impact for pharmacoepidemiological studies?;Pharmacoepidemiology and Drug Safety;2017-03-07

4. Investigating the Additive Interaction of QT-Prolonging Drugs in Older People Using Claims Data;Drug Safety;2016-11-29

5. Comparative evaluation of methods approximating drug prescription durations in claims data: modeling, simulation, and application to real data;Pharmacoepidemiology and Drug Safety;2016-09-16